Topics

Unions call on US antitrust regulators to block $63 billion 'AbbVieGan' merger

08:12 EDT 13 Sep 2019 | pharmaphorum

US antitrust authorities are coming under pressure from consumer groups and unions to block the proposed $63 billion merger of AbbVie and Allergan, according to a press report. Reuters reported that around a dozen advocacy groups and unions, inclu...

Original Article: Unions call on US antitrust regulators to block $63 billion 'AbbVieGan' merger

NEXT ARTICLE

More From BioPortfolio on "Unions call on US antitrust regulators to block $63 billion 'AbbVieGan' merger"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...